Dendreon: Healthy Competition Will Boost Profits
by | Posted 4.12.2012 | Post Comment (No Comments)

There are a lot of rumors floating around that could scare investors. Rumors that Dendreon (DNDN) could go under, rumors that its new ‘miracle’ drug Provenge is more of a monetary fiasco than a money-making tool, and rumors that Johnson & Johnson (JNJ) has the key to completely demolishing Dendreon: Zytiga.

Read the rest of this post @ DividendKings